Status
Conditions
Treatments
About
To evaluate the safety and tolerance of chronic administration of Retrovir (AZT) in HIV-infected adult patients without clinical manifestations of disease. To assess the efficacy of AZT therapy in the treatment of HIV disease in these patients.
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Exclusion Criteria
Co-existing Condition:
Patients with the following are excluded:
Concurrent Medication:
Excluded:
Patients are excluded if they have a history of symptoms characteristic of CDC class I or IV including any of the following:
Prior Medication:
Excluded:
Excluded within 4 weeks of study entry:
Excluded within 3 months of study entry:
Excluded within 4 months of study entry:
Patients must meet the following criteria:
Active drug or alcohol abuse sufficient in the investigator's opinion to prevent compliance with the study regimen.
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal